The findings revealed elevated MTFR2 expression in endometrial cancer, which subsequently facilitated tumor cell proliferation via the activation of the phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI3K)-protein kinase B (Akt) signaling pathway. This evidence concerns the gene AKT1 and endometrial cancer.